MDT

86.72

+0.52%↑

A

113.82

-1.09%↓

VEEV

172.29

-1.15%↓

HQY

80.9

-2.93%↓

PHR.US

9.12

+1.11%↑

MDT

86.72

+0.52%↑

A

113.82

-1.09%↓

VEEV

172.29

-1.15%↓

HQY

80.9

-2.93%↓

PHR.US

9.12

+1.11%↑

MDT

86.72

+0.52%↑

A

113.82

-1.09%↓

VEEV

172.29

-1.15%↓

HQY

80.9

-2.93%↓

PHR.US

9.12

+1.11%↑

MDT

86.72

+0.52%↑

A

113.82

-1.09%↓

VEEV

172.29

-1.15%↓

HQY

80.9

-2.93%↓

PHR.US

9.12

+1.11%↑

MDT

86.72

+0.52%↑

A

113.82

-1.09%↓

VEEV

172.29

-1.15%↓

HQY

80.9

-2.93%↓

PHR.US

9.12

+1.11%↑

Search

Simulations Plus Inc

Abierto

SectorSanidad

12.61 1.2

Resumen

Variación precio

24h

Actual

Mínimo

12.02

Máximo

12.63

Métricas clave

By Trading Economics

Ingresos

1.4M

676K

Ventas

961K

18M

Rentabilidad por dividendo

0.48

Margen de beneficios

3.67

Empleados

212

EBITDA

-3M

2.3M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+52.49% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.48%

2.45%

Próximas Ganancias

9 abr 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-139M

229M

Apertura anterior

11.41

Cierre anterior

12.61

Noticias sobre sentimiento de mercado

By Acuity

37%

63%

133 / 349 Clasificación en Healthcare

Simulations Plus Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

6 abr 2026, 23:17 UTC

Ganancias

Samsung Forecasts Record First-Quarter Operating Profit

6 abr 2026, 23:00 UTC

Acciones populares

Stocks to Watch: Health Insurers, Mawson, Owlet

6 abr 2026, 22:13 UTC

Principales Movimientos del Mercado

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6 abr 2026, 21:46 UTC

Adquisiciones, fusiones, absorciones

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6 abr 2026, 17:09 UTC

Principales Movimientos del Mercado

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6 abr 2026, 16:56 UTC

Noticias de Eventos Importantes

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6 abr 2026, 14:47 UTC

Principales Movimientos del Mercado

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7 abr 2026, 00:00 UTC

Noticias de Eventos Importantes

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6 abr 2026, 23:58 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6 abr 2026, 23:50 UTC

Charlas de Mercado

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6 abr 2026, 23:36 UTC

Charlas de Mercado

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6 abr 2026, 23:15 UTC

Charlas de Mercado

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6 abr 2026, 22:52 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

6 abr 2026, 22:52 UTC

Charlas de Mercado

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6 abr 2026, 22:14 UTC

Charlas de Mercado

Correction to Live Cattle Futures Article

6 abr 2026, 20:56 UTC

Charlas de Mercado

Mexican Private Consumption Fell in January -- Market Talk

6 abr 2026, 20:50 UTC

Charlas de Mercado

Energy & Utilities Roundup: Market Talk

6 abr 2026, 20:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

6 abr 2026, 19:58 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

6 abr 2026, 19:58 UTC

Charlas de Mercado

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6 abr 2026, 19:11 UTC

Charlas de Mercado

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6 abr 2026, 19:06 UTC

Charlas de Mercado

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6 abr 2026, 19:03 UTC

Charlas de Mercado

Global Energy Roundup: Market Talk

6 abr 2026, 19:03 UTC

Charlas de Mercado

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6 abr 2026, 18:36 UTC

Adquisiciones, fusiones, absorciones

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 abr 2026, 17:59 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6 abr 2026, 17:13 UTC

Adquisiciones, fusiones, absorciones

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 abr 2026, 16:33 UTC

Charlas de Mercado

Oil Futures Steady as Market Awaits Trump -- Market Talk

6 abr 2026, 16:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

6 abr 2026, 14:59 UTC

Ganancias

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Comparación entre iguales

Cambio de precio

Simulations Plus Inc previsión

Precio Objetivo

By TipRanks

52.49% repunte

Estimación a 12 Meses

Media 19 USD  52.49%

Máximo 19 USD

Mínimo 19 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Simulations Plus Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

4 ratings

2

Comprar

2

Mantener

0

Vender

Sentimiento

By Acuity

133 / 349 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat